Red Cell Immunology and Compatibility Testing

Rossi's Principles of Transfusion Medicine: Fourth Edition

Volumn , Issue , 2009, Pages 69-88

  Judd, W John ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870441702     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303513.ch5     Document Type: Chapter

References (50)

1. Alt F, Blackwell TK, Yancopoulos GD. Development of the primary antibody repertoire. Science 1987;248:1079-87.
2. Kuby TJ, Kindt TJ, Osborne BA, Goldsby RA. Immunology, 6th ed. New York: WH Freeman & Company, 2006.
3. Parslow TC. Immunoglobulins and immunoglobulin genes. In: Parslow TC, Stites DP, Terr AL, Imboden JB, eds. Medical immunology, 10th ed. New York: McGraw-Hill, 2001:95-114.
4. Chestnut RW, Grey HM. Antigen presentation by B cells and its significance in T-B interactions. Adv Immunol 1986;39:51-64.
5. Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976;6:511-19.
6. Silberstein LE. The antibody response to antigen. In: Nance S, ed. Alloimmunity: 1993 and beyond. Bethesda: AABB, 1993:25-47.
7. Race RR, Sanger R. Blood groups in man, 6th ed. Oxford: Blackwell Scientific Publications, 1965.
8. Klein HG, Anstee D. Mollison's blood transfusion in clinical medicine. 11th ed. Oxford: Blackwell Scientific Publications, 2005.
9. Reid ME, Lomas-Francis C. The blood group antigen FactsBook, 2nd ed. London: Academic Press, 2004.
10. Pollack W. Some physicochemical aspects of hemagglutination. Ann NY Acad Sci 1965;127:892-900.
11. Pollack W, Hager HJ, Reckel R, et al. A study of the forces involved in the second stage of hemagglutination. Transfusion 1965;5:158-83.
12. Cook GMW, Heard DH, Seamen GVF. A sialomucopeptide liberated by trypsin from the human erythrocyte. Nature (Lond) 1960;188:1011-12.
13. Judd WJ. Antibody elution from red cells. In: Bell CA, ed. Antigen- antibody reactions revisited. Arlington, VA: AABB, 1982:175-221.
14. Roback JD, Combs MR, Grossman BJ, Hillyer CD, eds. Technical manual, 16th ed. Bethesda, MD: AABB, 2008.
15. Shulman IA. Controversies in red cell compatibility testing. In: Nance SJ, ed. Immune destruction of red cells. Arlington, VA: AABB, 1989:171-99.
16. Price TH, ed. Standards for blood banks and transfusion services, 25th ed. Bethesda, MD: AABB, 2008.Oberman HA, Judd WJ. Cost containment in transfusion medicine: A view from the United States. In: Cash JD, ed. Progress in transfusion medicine, vol 3. Edinburgh: Churchill-Livingstone, 1988.
17. Issitt PD. Applied blood group serology, 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
18. Judd WJ. Judd's Methods in immunohematology, 3rd ed. Bethesda, MD: AABB Press, 2008.
19. Löw B, Messeter L. Antiglobulin tests in low-ionic strength salt solution for rapid antibody screening and crossmatching. Vox Sang 1974;26:53-61.
20. Nance S, Garratty G. A new technique to enhance antibody reactions using polyethylene glycol (abstract). Transfusion 1985;25:475.
21. Fitzsimmons JM, Morel PA. The effects of red blood cell suspending media on hemagglutination and the antiglobulin test. Transfusion 1979;19:81-5.
22. Lalezari P, Jiang AF. The manual Polybrene(r) test: A simple and rapid procedure for detection of red cell antibodies. Transfusion 1980;20:206-11.
23. Garratty G. The role of complement in blood group serology. CRC Crit Rev Clin Lab Sci 1985;20:25-56.
24. Lapierre Y, Rigal D, Adam J, et al. The gel test: A new way to detect red cell antigen-antibody reactions. Transfusion 1990;30:109-13.
25. Judd WJ, Steiner EA, Knafl PC. The gel test: sensitivity and specificity for unexpected antibodies to blood group antigens. Immunohematology 1997;13:132-5.
26. Judd WJ. 'New' blood bank technologies. Clin Lab Sci 1998;11:106-13.
27. Code of federal regulations Title 21 CFR, parts 606 and 660. Washington DC: US Government Printing Office, 2008 (revised annually).
28. Judd WJ. Testing for unexpected red cell antibodies-two or three reagent red cell samples. Immunohematology 1997;13:90-2.
29. Maffei LM, Johnson ST, Shulman IA, Steiner EA. Survey on pretransfusion testing. Transfusion 1998;38:343-49.
30. Shulman IA, Maffei LM, Downes KA. North American pretransfusion testing practices, 2001-2004: Results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004. Arch Pathol Lab Med 2005;129:984-9.
31. Judd WJ. Barnes BA, Steiner EA, et al. The evaluation of a positive direct antiglobulin test (autocontrol) revisited. Transfusion 1986;26:220-4.
32. Judd WJ. Investigation and management of immune hemolysis- autoantibodies and drugs. In: Wallace ME, Levitt J, eds. Current applications and interpretation of the direct antiglobulin test. Arlington, VA: AABB, 1988:47-103.
33. 1. Transfusion 1978;18:728-30.
34. Issitt PD. Antibodies reactive at 30 centigrade, room temperature and below. In: Butch SH, ed. Clinically significant and insignificant antibodies: A technical workshop. Washington, DC: AABB, 1979:13-28.
35. Judd WJ, Steiner EA, O'Donnell DB, Oberman HA. Discrepancies in ABO typing due to prozone: How safe is the immediate-spin crossmatch? Transfusion 1988;28:334-8.
36. Butch SH, Judd WJ, Steiner EA, et al. Electronic verification of donor- recipient compatibility: The computer crossmatch. Transfusion 1994;34:105-9.
37. Sawfenberg J, Hogman CF, Cassemar B. Computerized delivery control: A useful and safe complement to the type and screen compatibility testing. Vox Sang 1997;72:162-8.
38. Cox C, Enno A, Deveridge S, et al. Remote electronic release blood system. Transfusion 1997;37:960-4.
39. Chan A, Chan JC, Wong LY, Cheng G. From maximum surgical blood ordering schedule to unlimited computer crossmatching: Evolution of blood transfusion for surgical patients at a tertiary hospital in Hong Kong. Transfus Med 1996;6:121-4.
40. British Committee for Standardization in Haematology, Blood Transfusion Task Force. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 1996;6:273-83.
41. Georgsen J, Jensen F, Jeppesen S, et al. Transfusion service of the county of Funen. Organizational and economic aspects of restructuring. Ugeskr Laeger 1997;159:1758-62.
42. Food and Drug Administration. Computer crossmatch reviewer's checklist. Rockville, MD: CBER Office of Communication, Training, and Manufacturers Assistance, 1997.
43. Butch SH, Judd WJ. Requirements for the computer crossmatch (letter). Transfusion 1994;34:187.
44. Judd WJ. Requirements for the electronic crossmatch. Vox Sang 1998;74(S2):409-17.
45. Judd WJ. The electronic crossmatch: An alternative method to the immediate-spin crossmatch to detect ABO incompatibility. Advance 1998;10(15):16-23.
46. Steane EA, Steane SM, Montgomery SR, Pearson JR. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene(r)) test. Transfusion 1985;25:176-8.
47. Berry-Dortch S, Woodside C, Boral LI. Limitations of the immediate spin crossmatch when used for detecting ABO incompatibility. Transfusion 1985;25:540-4.
48. Physician's current procedural terminology: Chicago: American Medical Association, 2007.
49. Dzik WH. New technology for transfusion safety. Br J Haematol 2007;136:181-90.
50. New blood tracking system used across Europe. E-Health Europe Newsletter, December 17, 2007. [Available at http://ehealtheurope. net/news/3315 (accessed January 9, 2008).]